Industrials
Proto Script Pharmaceutical Corp.(PSCR)
Live Price
Offline$0.0002
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 → Jun 11, 2026
- Market Cap
- —
- Revenue Growth
- -10.5%
- EPS Growth
- -1493.8%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 10 bars · May 29, 2026 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Proto Script Pharmaceutical Corp. (PSCR) is a Industrials stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (May 29, 2026 → Jun 11, 2026). Baseline metrics include revenue growth of -10.5%, EPS growth of -1493.8%, a dividend yield of 0.0%. What stands out right now is revenue -10.5%, EPS -1493.8%, free cash flow -9.8% with operating margin -37.8% and ROIC 111.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PSCR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-10.5% vs +3.6% peer median
Operating Margin
Below sector median
-37.8% vs +16.9% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -10.5% and EPS is at -1493.8%, with operating margin around -37.8%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PSCR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PSCR Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PSCR and SPY.
Company Overview
Proto Script Pharmaceutical Corp.
Other OTC
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
- Leadership
- Michelle Rico
- IPO Date
- Apr 12, 2012
- Employees
- 13
- Street Address
- 9830 6th Street
- Mailing
- Rancho Cucamonga, CA, 91730
- Region
- Rancho Cucamonga, CA, US
- Reporting Currency
- USD
- Investor Line
- 855-476-7679
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.0
- Price/Book
- —
Growth
- Revenue
- -10.5%
- EPS
- -1493.8%
- Free Cash Flow
- -9.8%
Profitability
- Gross Margin
- 71.5%
- Operating Margin
- -37.8%
- Net Margin
- -910.4%
- ROE
- 5578.9%
- ROIC
- 111.0%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.30
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.